US Patent Issued to UNIVERSITE D'AIXMARSEILLE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, INSTITUT JEAN PAOLI & IRENE CALMETTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS on Aug. 26 for "Antibodies having specificity for nectin-4 and uses thereof" (French Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,206, issued on Aug. 26, was assigned to UNIVERSITE D'AIXMARSEILLE (Marseilles, France), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris), INSTITUT JEAN PAOLI & IRENE CALMETTES (Marseilles, France) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (Paris).

"Antibodies having specificity for nectin-4 and uses thereof" was invented by Marc Lopez (Marseilles, France) and Daniel Olive (Marseilles, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies having specificity for Nectin-4 and uses thereof, in particular for the treatment of cancer."

The patent was filed on Oct. 7, 2020, u...